Literature DB >> 11173626

Altered Proteoglycan Gene Expression in Human Biliary Cirrhosis.

Julia O Nagy, Mónika Gallai, Anna Sebestyén, Zsuzsa Schaff, Sándor Paku, András Jeney, Renato V Iozzo.   

Abstract

Proteoglycans play key roles in the physiological assembly of extracellular matrices and in the modulation of growth factor activities. During liver regeneration there is a profound remodelling of the connective tissue network with a concurrent alteration in proteoglycan gene expression. In the present study we have analyzed in detail the biochemical and molecular properties of the proteoglycans associated with biliary cirrhosis. The three major proteoglycans of human liver, namely decorin, syndecan and perlecan, were markedly elevated in the cirrhotic parenchyma as compared to normal liver tissue. Particularly elevated (eight fold) was the perlecan. This proteoglycan had not only heparan sulfate but also chondroitin and dermatan sulfate. Reverse transcriptase PCR revealed a marked enhancement of decorin and syndecan expression and detectable message for perlecan was found only in the cirrhotic liver. These results indicate that significant proteoglycan alterations are associated with the development of biliary cirrhosis and provide basis for future studies aimed at the characterization of the molecular events involved in the regulation of extracellular matrix deposition in this common human disease.

Entities:  

Year:  1997        PMID: 11173626     DOI: 10.1007/bf02893354

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  52 in total

1.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

2.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon.

Authors:  K G Vogel; M Paulsson; D Heinegård
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

5.  Distribution of the VLA family of integrins in normal and pathological human liver tissue.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

6.  Altered glycosaminoglycan composition in reactive and neoplastic human liver.

Authors:  I Kovalszky; G Pogany; G Molnar; A Jeney; K Lapis; S Karacsonyi; A Szecseny; R V Iozzo
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

7.  Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells.

Authors:  A M Gressner; S Schäfer
Journal:  J Clin Chem Clin Biochem       Date:  1989-03

8.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

9.  Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans.

Authors:  M Mali; P Jaakkola; A M Arvilommi; M Jalkanen
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

10.  Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth.

Authors:  M Ishihara; N S Fedarko; H E Conrad
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

View more
  1 in total

1.  The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis.

Authors:  J Köninger; N A Giese; M Bartel; F F di Mola; P O Berberat; P di Sebastiano; T Giese; M W Büchler; H Friess
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.